BR112017006622A2 - derivados de ácido borônico - Google Patents
derivados de ácido borônicoInfo
- Publication number
- BR112017006622A2 BR112017006622A2 BR112017006622-0A BR112017006622A BR112017006622A2 BR 112017006622 A2 BR112017006622 A2 BR 112017006622A2 BR 112017006622 A BR112017006622 A BR 112017006622A BR 112017006622 A2 BR112017006622 A2 BR 112017006622A2
- Authority
- BR
- Brazil
- Prior art keywords
- acid derivatives
- boronic acid
- boronic
- derivatives
- acid
- Prior art date
Links
- 150000001642 boronic acid derivatives Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/69—Boron compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic System
- C07F5/02—Boron compounds
- C07F5/025—Boronic and borinic acid compounds
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP14003389.5 | 2014-10-01 | ||
EP14003389 | 2014-10-01 | ||
PCT/EP2015/001973 WO2016050358A1 (en) | 2014-10-01 | 2015-10-01 | Boronic acid derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112017006622A2 true BR112017006622A2 (pt) | 2018-07-03 |
Family
ID=51751859
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112017006622-0A BR112017006622A2 (pt) | 2014-10-01 | 2015-10-01 | derivados de ácido borônico |
Country Status (21)
Country | Link |
---|---|
US (1) | US10669289B2 (pt) |
EP (1) | EP3201206B1 (pt) |
JP (1) | JP6662865B2 (pt) |
KR (1) | KR102457840B1 (pt) |
CN (1) | CN107001391B (pt) |
AU (1) | AU2015327345B9 (pt) |
BR (1) | BR112017006622A2 (pt) |
CA (1) | CA2963203A1 (pt) |
CL (1) | CL2017000792A1 (pt) |
DK (1) | DK3201206T3 (pt) |
ES (1) | ES2761774T3 (pt) |
IL (1) | IL251302B (pt) |
MX (1) | MX2017003999A (pt) |
MY (1) | MY186911A (pt) |
NZ (1) | NZ730981A (pt) |
PH (1) | PH12017500293A1 (pt) |
RU (1) | RU2717558C2 (pt) |
SG (1) | SG11201702628XA (pt) |
UA (1) | UA122672C2 (pt) |
WO (1) | WO2016050358A1 (pt) |
ZA (1) | ZA201703007B (pt) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2015327346B2 (en) | 2014-10-01 | 2019-12-05 | Merck Patent Gmbh | Boronic acid derivatives |
US9453018B2 (en) | 2014-10-01 | 2016-09-27 | Bristol-Myers Squibb Company | Pyrimidinones as factor XIa inhibitors |
MX2017004043A (es) | 2014-10-01 | 2017-07-04 | Merck Patent Gmbh | Derivados de acido boronico. |
CA2963186A1 (en) | 2014-10-01 | 2016-04-07 | Merck Patent Gmbh | Boronic acid derivatives |
KR102534947B1 (ko) * | 2017-01-18 | 2023-05-23 | 프린시피아 바이오파마, 인코퍼레이티드 | 면역프로테아좀 억제제 |
KR20200040295A (ko) * | 2017-08-24 | 2020-04-17 | 메르크 파텐트 게엠베하 | 보론산 유도체 |
CN111065619B (zh) * | 2017-08-29 | 2022-08-12 | 浙江海正药业股份有限公司 | (E)-α,β-不饱和酰胺化合物及其制备方法和用途 |
WO2019075386A1 (en) * | 2017-10-13 | 2019-04-18 | The Regents Of The University Of California | MODULATORS OF MTORC1 |
WO2019099576A1 (en) | 2017-11-16 | 2019-05-23 | Principia Biopharma Inc. | Immunoproteasome inhibitors |
NZ764393A (en) * | 2017-11-16 | 2023-11-24 | Principia Biopharma Inc | Immunoproteasome inhibitors |
BR112021001359A2 (pt) | 2018-07-26 | 2021-04-20 | Merck Patent Gmbh | derivados de ácido borônico |
CN113135944A (zh) * | 2020-01-19 | 2021-07-20 | 首药控股(北京)有限公司 | 硼酸衍生物 |
CN113135943A (zh) * | 2020-01-19 | 2021-07-20 | 首药控股(北京)有限公司 | 硼酸衍生物 |
IL310390A (en) | 2021-07-29 | 2024-03-01 | Merck Patent Gmbh | Crystalline forms of [(R1)-2-benzofuran-3-yl)-1-{[(R4, R2, S1)-7-oxabicyclo[2.2.1]heptan-2-yl]formamido}ethyl]boronic acid, Their adducts and their use |
WO2023061445A1 (zh) * | 2021-10-14 | 2023-04-20 | 首药控股(北京)股份有限公司 | 硼酸衍生物 |
WO2023232830A1 (en) | 2022-06-02 | 2023-12-07 | Merck Patent Gmbh | Boronic acid adducts |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5658885A (en) * | 1993-04-27 | 1997-08-19 | The Dupont Merck Pharmaceutical Company | Amidino and guanidino substituted boronic acid inhibitors of trypsin-like enzymes |
US5462964A (en) * | 1993-10-20 | 1995-10-31 | The Du Pont Merck Pharmaceutical Company | Dipeptide boronic acid inhibitors of trypsin-like enzymes |
IL111175A0 (en) | 1993-10-07 | 1994-12-29 | Du Pont Merck Pharma | Electrophilic peptide analogs as inhibitors of trypsin-like serine proteases and pharmaceutical compositions containing them |
AU5788800A (en) * | 1999-07-07 | 2001-01-22 | Du Pont Pharmaceuticals Company | Peptide boronic acid inhibitors of hepatitis c virus protease |
JP2006509034A (ja) * | 2002-09-09 | 2006-03-16 | トライジェン・リミテッド | 選択性トロンビン阻害のための非経口製剤に有用なボロン酸塩 |
US7576206B2 (en) * | 2003-08-14 | 2009-08-18 | Cephalon, Inc. | Proteasome inhibitors and methods of using the same |
CN1867572B (zh) * | 2003-08-14 | 2012-03-28 | 赛福伦公司 | 蛋白酶体抑制剂及其使用方法 |
AR075090A1 (es) * | 2008-09-29 | 2011-03-09 | Millennium Pharm Inc | Derivados de acido 1-amino-2-ciclobutiletilboronico inhibidores de proteosoma,utiles como agentes anticancerigenos, y composiciones farmaceuticas que los comprenden. |
NZ603364A (en) | 2010-04-22 | 2015-06-26 | Mars Inc | Inhibitors of arginase and their therapeutic applications |
EP2793900B1 (en) * | 2011-12-22 | 2018-08-22 | Ares Trading S.A. | Alpha-amino boronic acid derivatives, selective immunoproteasome inhibitors |
JP6464176B2 (ja) | 2014-01-31 | 2019-02-06 | ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company | 芳香族p2’基を有する第xia因子阻害剤としてのマクロ環 |
SG11201702463YA (en) | 2014-10-01 | 2017-04-27 | Janssen Pharmaceuticals Inc | Mono- or di-substituted indole derivatives as dengue viral replication inhibitors |
NO2721243T3 (pt) | 2014-10-01 | 2018-10-20 | ||
MX2017004043A (es) | 2014-10-01 | 2017-07-04 | Merck Patent Gmbh | Derivados de acido boronico. |
CA2963186A1 (en) | 2014-10-01 | 2016-04-07 | Merck Patent Gmbh | Boronic acid derivatives |
AU2015327346B2 (en) | 2014-10-01 | 2019-12-05 | Merck Patent Gmbh | Boronic acid derivatives |
ME03344B (me) | 2014-10-01 | 2019-10-20 | Janssen Pharmaceuticals Inc | Mono- ili di-supstituisani indoli kao inнibitori replikacije denga virusa |
-
2015
- 2015-10-01 KR KR1020177011562A patent/KR102457840B1/ko active IP Right Grant
- 2015-10-01 CN CN201580053501.9A patent/CN107001391B/zh active Active
- 2015-10-01 MY MYPI2017701058A patent/MY186911A/en unknown
- 2015-10-01 BR BR112017006622-0A patent/BR112017006622A2/pt not_active Application Discontinuation
- 2015-10-01 US US15/516,427 patent/US10669289B2/en active Active
- 2015-10-01 DK DK15778613.8T patent/DK3201206T3/da active
- 2015-10-01 MX MX2017003999A patent/MX2017003999A/es active IP Right Grant
- 2015-10-01 AU AU2015327345A patent/AU2015327345B9/en active Active
- 2015-10-01 EP EP15778613.8A patent/EP3201206B1/en active Active
- 2015-10-01 WO PCT/EP2015/001973 patent/WO2016050358A1/en active Application Filing
- 2015-10-01 ES ES15778613T patent/ES2761774T3/es active Active
- 2015-10-01 NZ NZ730981A patent/NZ730981A/en unknown
- 2015-10-01 JP JP2017518070A patent/JP6662865B2/ja active Active
- 2015-10-01 CA CA2963203A patent/CA2963203A1/en active Pending
- 2015-10-01 UA UAA201704168A patent/UA122672C2/uk unknown
- 2015-10-01 RU RU2017115192A patent/RU2717558C2/ru active
- 2015-10-01 SG SG11201702628XA patent/SG11201702628XA/en unknown
-
2017
- 2017-02-16 PH PH12017500293A patent/PH12017500293A1/en unknown
- 2017-03-21 IL IL251302A patent/IL251302B/en active IP Right Grant
- 2017-03-31 CL CL2017000792A patent/CL2017000792A1/es unknown
- 2017-04-28 ZA ZA2017/03007A patent/ZA201703007B/en unknown
Also Published As
Publication number | Publication date |
---|---|
RU2717558C2 (ru) | 2020-03-24 |
KR20170067802A (ko) | 2017-06-16 |
CN107001391B (zh) | 2020-11-27 |
NZ730981A (en) | 2024-01-26 |
UA122672C2 (uk) | 2020-12-28 |
AU2015327345B9 (en) | 2020-06-18 |
DK3201206T3 (da) | 2019-12-16 |
JP6662865B2 (ja) | 2020-03-11 |
RU2017115192A (ru) | 2018-11-06 |
IL251302B (en) | 2020-03-31 |
US10669289B2 (en) | 2020-06-02 |
EP3201206B1 (en) | 2019-09-18 |
PH12017500293A1 (en) | 2017-06-28 |
EP3201206A1 (en) | 2017-08-09 |
CL2017000792A1 (es) | 2017-11-10 |
KR102457840B1 (ko) | 2022-10-21 |
SG11201702628XA (en) | 2017-04-27 |
AU2015327345A1 (en) | 2017-05-18 |
CN107001391A (zh) | 2017-08-01 |
JP2017531646A (ja) | 2017-10-26 |
RU2017115192A3 (pt) | 2019-03-26 |
US20180179232A1 (en) | 2018-06-28 |
AU2015327345B2 (en) | 2019-12-05 |
ES2761774T3 (es) | 2020-05-21 |
WO2016050358A1 (en) | 2016-04-07 |
MY186911A (en) | 2021-08-26 |
IL251302A0 (en) | 2017-05-29 |
MX2017003999A (es) | 2018-02-09 |
ZA201703007B (en) | 2022-05-25 |
CA2963203A1 (en) | 2016-04-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112017006622A2 (pt) | derivados de ácido borônico | |
DK3134402T3 (da) | 4-amino-imidazoquinolinforbindelser | |
DK3183051T3 (da) | Væske-til-luftmembranenergivekslere | |
DK3211743T3 (da) | Ø-til-netværk-omskiftningsfremgangsmåde | |
DK3222714T3 (da) | Phytasemutanter | |
DK3119396T3 (da) | Muscarinreceptoragonister | |
SG11201702620SA (en) | Boronic acid derivatives | |
DK3006072T3 (da) | Karadgang | |
SG11201702625PA (en) | Boronic acid derivatives | |
SG11201702623TA (en) | Boronic acid derivatives | |
DK3231803T3 (da) | Dihydroindolizinonderivat | |
CL2016002165A1 (es) | Compuestos de aminocarbonilcarbamato | |
CL2015001019S1 (es) | Ampolleta | |
DE112015001664A5 (de) | Betätigungsaktuator | |
DK3131898T3 (da) | Fluoroalkylfluorenderivativer | |
DK3191466T3 (da) | Azetidinyloxyphenylpyrrolidinforbindelser | |
DK3183340T3 (da) | Termolabile exonukleaser | |
DK3154703T3 (da) | Fuldkappe-snekkecentrifuge | |
DK3154689T3 (da) | Komplekser | |
DK3110439T3 (da) | Pcsk9-vacciner | |
DK3672977T3 (da) | Boronsyrederivater | |
DE112015005041A5 (de) | Gargerätevorrichtung | |
DK3154945T3 (da) | Komplekser | |
DE102014000623A8 (de) | Halbhohlnietelement | |
DK3009858T3 (da) | Skyradar |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] |